What Sets Us Apart

Multiple myeloma—a cancer that forms in a type of blood cell, called a plasma cell—is a chronic disease that requires ongoing care and monitoring. Specialists at NYU Langone’s Perlmutter Cancer Center work together to diagnose and treat people with this condition.

Medical hematologist–oncologists, radiation oncologists, social workers, and integrative medicine specialists partner with you throughout diagnosis and treatment. They may order sophisticated diagnostic and genetic tests, some of which were developed at NYU Langone, to guide treatment planning. They can also draw upon recent medical advances to provide you with customized therapy. Our doctors have conducted clinical trials to help establish a number of the medications in use today, including immune therapies and targeted medications.


At NYU Langone’s Perlmutter Cancer Center, a National Cancer Institute-designated cancer center, we personalize the care of every patient.More About Perlmutter Cancer Center

CLINICAL TRIALS and Research Studies

Our teams of physicians and scientists work together across multiple disciplines to bring our patients the most innovative clinical trials.Find a Clinical Trial

Treatment at NYU Langone

Because plasma cells grow very slowly, some people without symptoms may have a period of watchful waiting, when doctors monitor the condition but don’t treat it. Others may receive a combination of medical therapies with or without stem cell transplantation or radiation therapy.

Our Experts

View All Doctors

More Multiple Myeloma Resources